Patients with high-risk skin cancer have new treatment option
Hundreds of patients with a type of advanced skin cancer are set to benefit from a new treatment, dabrafenib plus trametinib.
New “life changing” procedure can be offered to adults with severe asthma on NHS
Procedure could be an option for adults with severe asthma whose symptoms cannot be adequately controlled with drugs
Feedback encouraged to allow use of life extending treatment on NHS for those with blood cancer
CAR-T considered to be an exciting innovation which can cure some patients but very expensive
Antibiotics should not be issued as first line of treatment for a cough, says NICE and PHE
People should take honey or cough medicines instead but speak to their GP if it persists for longer than three weeks
Latest news headlines
-
NICE would welcome further discussions about access to spinal muscular atrophy drug nusinersen
NICE hopes for further talks over nusinersen for treating a rare genetic disorder; spinal muscular atrophy (SMA).
14 August 2018
-
NICE guideline set to address variation in provision of services for adults with cerebral palsy
NICE has published a draft guideline on the care and support adults with cerebral palsy should receive.
16 July 2018
-
Launch of new master’s degree in Evaluation of Health Care Interventions and Outcomes
A new master’s degree in healthcare decision making has been launched by London School of Economics and Political Science (LSE) in collaboration with NICE.
12 July 2018
-
Cancer drug for children recommended after becoming cost effective for NHS patients
Around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta
12 July 2018
-
More people to be given dye to highlight brain tumours to surgeons say NICE
Hundreds of patients a year set to benefit from roll out of dye to all of England’s neurosurgical units
10 July 2018
-
Antibiotics should be restricted for COPD
Healthcare professionals should consider the risk of antimicrobial resistance when deciding whether antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).
09 July 2018